Namodenoson Shows Protective Effects Beyond Liver Cancer in Can-Fite’s Pivotal Study
Can-Fite BioPharma (NYSE: CANF) announced the publication of an innovative study in the European Society of Medicine...
Can-Fite BioPharma (NYSE: CANF) announced the publication of an innovative study in the European Society of Medicine...
Cancer, which was once considered a fatal disease, is now treatable due to the advancements in healthcare and technologies. However,...
Climate change is driving more extreme heat and more air pollution from wildfires, each of which put human health at...
GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the...
UK pharmaceutical giant AstraZeneca has admitted that its Covid-19 vaccine can lead to a rare side effect known as Thrombosis...
Blood thinners are a class of medications that help prevent blot clots from forming in an artery (a type of...